Cargando…
Effectiveness of a single lead AliveCor electrocardiogram application for the screening of atrial fibrillation: A systematic review
BACKGROUND: Increasing prevalence of atrial fibrillation has a significant impact on health, society, and healthcare resource utilization, due to increased morbidity, mortality, risk of stroke, and reduction in quality of life. Early diagnosis allows for treatment initiation, a reduction in complica...
Autores principales: | Hall, Angela, Mitchell, Andrew Robert John, Wood, Lisa, Holland, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386997/ https://www.ncbi.nlm.nih.gov/pubmed/32791751 http://dx.doi.org/10.1097/MD.0000000000021388 |
Ejemplares similares
-
Single-lead ECGs (AliveCor) are a feasible, cost-effective and safer alternative to 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation
por: Bray, Jonathan James Hyett, et al.
Publicado: (2021) -
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019) -
Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
por: Mathew, Savio, et al.
Publicado: (2021) -
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
por: Ellins, Elizabeth A, et al.
Publicado: (2023) -
Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor
por: Puranik, Shriya, et al.
Publicado: (2021)